Device Trial Radar · NCT06132945
A Study of Cabozantinib and Nivolumab With Radiation Therapy for People With Renal Cell Carcinoma That Has Spread to the Brain
Last checked: Nov 19, 2026Latest source record: Nov 17, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
2
Actual
Start
Nov 10, 2023
Primary completion
Nov 2027
Study completion Nov 2027
Sponsor
- Lead sponsor
- Memorial Sloan Kettering Cancer CenterAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Exelixis
- First posted
- Nov 15, 2023
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to find out whether the combination of cabozantinib, nivolumab, and radiation therapy is a safe and effective treatment that causes few or mild side effects in people with renal cell cancer that has spread to the brain. The researches will also look at how the study treatment affects the quality of life of participants. They will measure the quality of life by having participants complete questionnaires.
Conditions
- Metastatic Renal Cell Carcinoma
- Brain Metastases
Interventions
CabozantinibDrug
Cabozantinib (40 mg PO daily)
NivolumabDevice
Nivolumab (480 mg IV Day 1)
Stereotactic Radiosurgery (SRS)Radiation
Radiation will be stereotactic radiosurgery, delivered over 1-5 fractions with a total dose of 18-30Gy depending on fractionation schedule per the discretion of the treating radiation oncologist.
Primary outcomes
What the sponsor says the trial is designed to measure.
- percent of enrolled patients who are able to tolerate treatmentTime frame: 56-day
Locations
7 sites in 1 country. Site status is shown where the registry gives one.
Memorial Sloan Kettering Basking Ridge (All Protocol Activities)
Basking Ridge, New Jersey
Memorial Sloan Kettering Monmouth (All Protocol Activities)
Middletown, New Jersey
Memorial Sloan Kettering Bergen (All Protocol Activities)
Montvale, New Jersey
4 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.